Search

everythinglearnresearchcommunity

for

Search:↓

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Targeting Vδ1+T-cells may help treat alopecia areata.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Immune cells affect hair growth and could lead to new hair loss treatments.

Fucoidan reduces bone cell formation by affecting T-cell activity.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.